Latest News & Features
Genetics
An individual gene profile provides a window into a person’s medical future, by examining DNA samples, but what are the best ways of regulating this developing technology? LSIPR looks at the challenges and possible solutions. 19 February 2014
Americas
The US Supreme Court has again reversed a Federal Circuit decision, this time over burden of proof, says Matthew Nielsen. 19 February 2014
Big Pharma
Several of the world’s 10 top-selling drugs lose exclusivity this year. LSIPR takes a look at the products, their major competitors, and their manufacturers’ strategies for keeping a grasp of market share. 19 February 2014
Asia-Pacific
Australia’s antitrust regulator has launched proceedings against Pfizer’s Australian arm, accusing it of abusing its power when supplying cholesterol-lowering drug atorvastatin to pharmacies. 18 February 2014
Americas
Novartis has announced it will acquire biotechnology company CoStim for an undisclosed sum. 18 February 2014
Americas
Humanitarian organisation Médecins Sans Frontières has criticised the US for pressuring the Indian government to review its patent policies. 17 February 2014
Biotechnology
Baker & McKenzie LLP has added to its IP team with the appointment of Hiroshi Sheraton as partner in its London office. 17 February 2014
Americas
Myriad and its rival genetic diagnostics company Gene by Gene have agreed to settle their patent infringement case related to BRCA tests. 13 February 2014
Americas
The US Chamber of Commerce has criticised India’s “recent pattern of pharma patent denials”, which it says “are not about access to medicine”. 12 February 2014
Americas
Pharmaceutical company Merck and Samsung Bioepis, a joint venture between South Korean firm Samsung and Biogen, have agreed to work on a diabetes treatment. 11 February 2014